Position in ARVN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,256,196
-$307,536 QoQ
Shares Held
151,167
+2.5% QoQ
Ownership
0.231%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 198 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 44%
Shared 0%
None 56%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. ARVN ranks #133 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in ARVN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,256,196 | 151,167 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $1,563,732 | 147,522 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $1,723,067 | 145,284 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,640,474 | 192,544 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,636,841 | 222,397 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,605,002 | 228,633 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $4,164,107 | 217,220 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $5,674,406 | 230,386 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $4,962,153 | 186,407 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $5,570,942 | 134,955 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $3,539,595 | 85,996 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,251,362 | 63,715 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $4,322,947 | 174,172 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,078,923 | 185,905 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,025,783 | 176,141 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $7,773,914 | 174,734 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,371,826 | 198,903 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $11,604,807 | 172,434 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $15,835,687 | 192,789 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $22,064,342 | 268,488 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $73,472,707 | 954,191 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $11,640,075 | 176,098 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $3,033,783 | 35,721 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,912,105 | 165,697 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $11,913,439 | 355,201 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $454,825 | 11,286 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||